If you need more lookups,
subscriptions start at $34 USD/month.
Adam Shilling Location
Wilmington, DE, US
Adam Shilling Work
Chief Development Officer (Part-time) @ (September 2022 - Present)
President and Founder @ (April 2022 - Present)
Vice President Early Development and Regulatory Affairs @ (April 2019 - April 2022)
Executive Director, Regulatory Affairs @ (January 2007 - April 2019)
Principal Research Scientist @ (January 2000 - January 2007)
Adam Shilling Education
Oregon State University
Ph.D. (Toxicology)
1996-2000
Long Island University, Southampton Campus
B.S. (Marine Biology)
1992-1996
Adam Shilling Skills
Regulatory Affairs
Drug Development
Drug Metabolism
Toxicology
Drug Discovery
ADME
Clinical Development
Regulatory Submissions
CRO
IND
FDA
Oncology
Pharmacology
DMPK
NDA
Regulatory Requirements
Pharmaceutics
Pharmaceutical Industry
Lifesciences
GLP
Biopharmaceuticals
Biotechnology
CRO Management
Clinical Research
Clinical Trials
GCP
Pharmacokinetics
Sop
Standard Operating Procedure (SOP)
Data Analysis
Standard Operating Procedure Sop
Program Management
Management
Leadership
Standard Operating Procedure
Adam Shilling Summary
Adam Shilling, based in Wilmington, DE, US, is currently a Chief Development Officer (Part-time) at Nanocan Therapeutics Corporation. Adam Shilling brings experience from previous roles at AS Pharma Consulting, LLC, Prelude Therapeutics Incorporated, Incyte Pharmaceuticals and Wyeth Research. Adam Shilling holds a 1996 - 2000 Ph.D. in Toxicology @ Oregon State University. With a robust skill set that includes Regulatory Affairs, Drug Development, Drug Metabolism, Toxicology, Drug Discovery and more. Adam Shilling has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Adam Shilling?
Find contact details for 700 million professionals.